The British Society for Rheumatology Guideline for the Management of Gout
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The British Society for Rheumatology Guideline for the Management of Gout
Authors
Keywords
-
Journal
RHEUMATOLOGY
Volume 56, Issue 7, Pages e1-e20
Publisher
Oxford University Press (OUP)
Online
2017-05-26
DOI
10.1093/rheumatology/kex156
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding—Part II: analgesics and other drugs used in rheumatology practice: Table 1
- (2016) Julia Flint et al. RHEUMATOLOGY
- BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding—Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids: Table 1
- (2016) Julia Flint et al. RHEUMATOLOGY
- Challenges Faced by Patients in Gout Treatment
- (2016) Jasvinder A. Singh JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Individual non-steroidal anti-inflammatory drugs and risk of acute kidney injury: A systematic review and meta-analysis of observational studies
- (2015) Patompong Ungprasert et al. European Journal of Internal Medicine
- Polymorphisms of uric transporter proteins in the pathogenesis of gout in a Chinese Han population
- (2015) W. Wan et al. GENETICS AND MOLECULAR RESEARCH
- Gout in Pregnancy: A Case Report and Review of the Literature
- (2015) Teelkien R. van Veen et al. GYNECOLOGIC AND OBSTETRIC INVESTIGATION
- Australian and New Zealand recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion in the 3e Initiative
- (2015) Scott W. Graf et al. International Journal of Rheumatic Diseases
- Gout and risk of chronic kidney disease and nephrolithiasis: meta-analysis of observational studies
- (2015) Matthew J Roughley et al. ARTHRITIS RESEARCH & THERAPY
- Alcohol Quantity and Type on Risk of Recurrent Gout Attacks: An Internet-based Case-crossover Study
- (2014) Tuhina Neogi et al. AMERICAN JOURNAL OF MEDICINE
- Cost-Effectiveness of Allopurinol and Febuxostat for the Management of Gout
- (2014) Eric Jutkowitz et al. ANNALS OF INTERNAL MEDICINE
- Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study
- (2014) Chang-Fu Kuo et al. ANNALS OF THE RHEUMATIC DISEASES
- Successful Treatment of Refractory Gout Using Combined Therapy Consisting of Febuxostat and Allopurinol in a Patient with Chronic Renal Failure
- (2014) Michitaka Maekawa et al. INTERNAL MEDICINE
- Eligibility for and Prescription of Urate-Lowering Treatment in Patients With Incident Gout in England
- (2014) Chang-Fu Kuo et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Rilonacept for Gout Flare Prevention in Patients Receiving Uric Acid-lowering Therapy: Results of RESURGE, a Phase III, International Safety Study
- (2014) J. S. Sundy et al. JOURNAL OF RHEUMATOLOGY
- Effect of Urate-lowering Therapies on Renal Disease Progression in Patients with Hyperuricemia
- (2014) G. D. Levy et al. JOURNAL OF RHEUMATOLOGY
- Optimizing current treatment of gout
- (2014) Frances Rees et al. Nature Reviews Rheumatology
- Prophylaxis for acute gout flares after initiation of urate-lowering therapy
- (2014) A. Latourte et al. RHEUMATOLOGY
- Gout patients have an increased risk of developing most cancers, especially urological cancers
- (2014) C-J Chen et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Up-titration of allopurinol in patients with gout
- (2014) Claudine G. Jennings et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Treatment of acute gout: A systematic review
- (2014) Puja P. Khanna et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Medical Management to Prevent Recurrent Nephrolithiasis in Adults: A Systematic Review for an American College of Physicians Clinical Guideline
- (2013) Howard A. Fink et al. ANNALS OF INTERNAL MEDICINE
- A systematic review of ultrasonography in gout and asymptomatic hyperuricaemia
- (2013) Priya V Chowalloor et al. ANNALS OF THE RHEUMATIC DISEASES
- Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative
- (2013) Francisca Sivera et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinically Insignificant Effect of Supplemental Vitamin C on Serum Urate in Patients With Gout: A Pilot Randomized Controlled Trial
- (2013) Lisa K. Stamp et al. ARTHRITIS AND RHEUMATISM
- Questionnaire survey evaluating disease-related knowledge for 149 primary gout patients and 184 doctors in South China
- (2013) Qian-Hua Li et al. CLINICAL RHEUMATOLOGY
- Efficacy and Tolerability of Febuxostat in Hyperuricemic Patients With or Without Gout: A Systematic Review and Meta-Analysis
- (2013) Peng Ye et al. CLINICAL THERAPEUTICS
- Non-steroidal anti-inflammatory drugs and chronic kidney disease progression: a systematic review
- (2013) P. Nderitu et al. FAMILY PRACTICE
- Efficacy and Tolerability of Probenecid as Urate-lowering Therapy in Gout; Clinical Experience in High-prevalence Population
- (2013) K. Pui et al. JOURNAL OF RHEUMATOLOGY
- Rilonacept for gout flare prevention during initiation of uric acid-lowering therapy: results from the PRESURGE-2 international, phase 3, randomized, placebo-controlled trial
- (2013) Essack Mitha et al. RHEUMATOLOGY
- Health-related quality of life in gout: a systematic review
- (2013) Priyanka Chandratre et al. RHEUMATOLOGY
- A systematic review and meta-analysis on the safety and efficacy of febuxostat versus allopurinol in chronic gout
- (2013) Labib I. Faruque et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Clinical and Health Care Use Characteristics of Patients Newly Starting Allopurinol, Febuxostat, and Colchicine for the Treatment of Gout
- (2013) Seoyoung C. Kim et al. ARTHRITIS CARE & RESEARCH
- Treatment of Acute Gouty Arthritis in Complex Hospitalized Patients With Anakinra
- (2013) Pradipta Ghosh et al. ARTHRITIS CARE & RESEARCH
- Rilonacept in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator
- (2013) Robert A Terkeltaub et al. ARTHRITIS RESEARCH & THERAPY
- Common dysfunctional variants in ABCG2 are a major cause of early-onset gout
- (2013) Hirotaka Matsuo et al. Scientific Reports
- Use of Diuretics and Risk of Incident Gout: A Population-Based Case-Control Study
- (2013) Saskia Bruderer et al. Arthritis & Rheumatology
- CArdiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular ComoRbiditiES
- (2012) William B. White et al. AMERICAN HEART JOURNAL
- Initiation of Allopurinol at First Medical Contact for Acute Attacks of Gout: A Randomized Clinical Trial
- (2012) Thomas H. Taylor et al. AMERICAN JOURNAL OF MEDICINE
- Nature Versus Nurture in Gout: A Twin Study
- (2012) Eswar Krishnan et al. AMERICAN JOURNAL OF MEDICINE
- Management of Gouty Arthritis in Patients With Chronic Kidney Disease
- (2012) Abdul A. Abdellatif et al. AMERICAN JOURNAL OF THERAPEUTICS
- Epidemiology of gout and hyperuricaemia in Italy during the years 2005–2009: a nationwide population-based study
- (2012) Gianluca Trifirò et al. ANNALS OF THE RHEUMATIC DISEASES
- Effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extract on frequency of gout flares: a proof-of-concept randomised controlled trial
- (2012) Nicola Dalbeth et al. ANNALS OF THE RHEUMATIC DISEASES
- Patient and provider barriers to effective management of gout in general practice: a qualitative study: Figure 1
- (2012) Karen Spencer et al. ANNALS OF THE RHEUMATIC DISEASES
- Gout: why is this curable disease so seldom cured?
- (2012) Michael Doherty et al. ANNALS OF THE RHEUMATIC DISEASES
- Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study
- (2012) Frances Rees et al. ANNALS OF THE RHEUMATIC DISEASES
- Cherry consumption and decreased risk of recurrent gout attacks
- (2012) Yuqing Zhang et al. ARTHRITIS AND RHEUMATISM
- Starting dose is a risk factor for allopurinol hypersensitivity syndrome: A proposed safe starting dose of allopurinol
- (2012) Lisa K. Stamp et al. ARTHRITIS AND RHEUMATISM
- Patients’ knowledge and beliefs concerning gout and its treatment: a population based study
- (2012) Leslie R Harrold et al. BMC MUSCULOSKELETAL DISORDERS
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Human Leukocyte Antigen-B Genotype and Allopurinol Dosing
- (2012) M S Hershfield et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: Results from a cross-sectional survey
- (2012) Puja P Khanna et al. Health and Quality of Life Outcomes
- The Experience and Impact of Living With Gout
- (2012) Karen Lindsay et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Uric acid levels predict survival in men with amyotrophic lateral sclerosis
- (2012) Sabrina Paganoni et al. JOURNAL OF NEUROLOGY
- Febuxostat Hypersensitivity
- (2012) A. M. ABELES JOURNAL OF RHEUMATOLOGY
- Gout, Stone Composition and Urinary Stone Risk: A Matched Case Comparative Study
- (2012) Giovanni Scala Marchini et al. JOURNAL OF UROLOGY
- Use of Diuretics and the Risk of Gouty Arthritis: A Systematic Review
- (2012) Berdine A.A. Hueskes et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Challenges Associated with the Management of Gouty Arthritis in Patients with Chronic Kidney Disease: A Systematic Review
- (2012) Rodolfo V. Curiel et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Rilonacept (interleukin-1 trap) for prevention of gout flares during initiation of uric acid-lowering therapy: Results from a phase III randomized, double-blind, placebo-controlled, confirmatory efficacy study
- (2012) H. Ralph Schumacher et al. ARTHRITIS CARE & RESEARCH
- 2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis
- (2012) Dinesh Khanna et al. ARTHRITIS CARE & RESEARCH
- 2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia
- (2012) Dinesh Khanna et al. ARTHRITIS CARE & RESEARCH
- Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study
- (2011) N. Schlesinger et al. ANNALS OF THE RHEUMATIC DISEASES
- Mortality due to coronary heart disease and kidney disease among middle-aged and elderly men and women with gout in the Singapore Chinese Health Study
- (2011) Gim Gee Teng et al. ANNALS OF THE RHEUMATIC DISEASES
- Reply
- (2011) Robert A. Terkeltaub et al. ARTHRITIS AND RHEUMATISM
- A two-stage approach to the treatment of hyperuricemia in gout: The “dirty dish” hypothesis
- (2011) Fernando Perez-Ruiz et al. ARTHRITIS AND RHEUMATISM
- Gout treatment and comorbidities: a retrospective cohort study in a large US managed care population
- (2011) Paola Primatesta et al. BMC MUSCULOSKELETAL DISORDERS
- Effect of Prophylaxis on Gout Flares After the Initiation of Urate-Lowering Therapy: Analysis of Data From Three Phase III Trials
- (2011) Robert L. Wortmann et al. CLINICAL THERAPEUTICS
- Improved management of acute gout during hospitalization following introduction of a protocol
- (2011) Narainraj KAMALARAJ et al. International Journal of Rheumatic Diseases
- Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment
- (2011) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety and Efficacy of Febuxostat Treatment in Subjects with Gout and Severe Allopurinol Adverse Reactions
- (2011) S. CHOHAN JOURNAL OF RHEUMATOLOGY
- The Risk of Parkinson Disease Associated with Urate in a Community-Based Cohort of Older Adults
- (2011) S. Jain et al. NEUROEPIDEMIOLOGY
- Allopurinol pharmacogenetics: assessment of potential clinical usefulness
- (2011) Issam Zineh et al. PHARMACOGENOMICS
- Identification of Intraarticular and Periarticular Uric Acid Crystals with Dual-Energy CT: Initial Evaluation
- (2011) Katrina N. Glazebrook et al. RADIOLOGY
- Effect of oral vitamin C supplementation on serum uric acid: A meta-analysis of randomized controlled trials
- (2011) Stephen P. Juraschek et al. ARTHRITIS CARE & RESEARCH
- Illness perceptions in patients with gout and the relationship with progression of musculoskeletal disability
- (2011) Nicola Dalbeth et al. ARTHRITIS CARE & RESEARCH
- Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat Gouty Arthritis by suppressing inflammation: results of a randomized, dose-ranging study
- (2011) Naomi Schlesinger et al. ARTHRITIS RESEARCH & THERAPY
- Predicting the risk of end-stage renal disease in the population-based setting: a retrospective case-control study
- (2011) Eric S Johnson et al. BMC Nephrology
- Epidemiology of gout in women: Fifty-two-year followup of a prospective cohort
- (2010) Vidula Bhole et al. ARTHRITIS AND RHEUMATISM
- High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study
- (2010) Robert A. Terkeltaub et al. ARTHRITIS AND RHEUMATISM
- Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment
- (2010) Lisa K. Stamp et al. ARTHRITIS AND RHEUMATISM
- Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk
- (2010) M. Goicoechea et al. Clinical Journal of the American Society of Nephrology
- The relationship between uric acid levels and Huntington's disease progression
- (2010) Peggy Auinger et al. MOVEMENT DISORDERS
- The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
- (2010) Michael A Becker et al. ARTHRITIS RESEARCH & THERAPY
- Urate as a Predictor of the Rate of Clinical Decline in Parkinson Disease
- (2009) Alberto Ascherio ARCHIVES OF NEUROLOGY
- A Benefit-Risk Assessment of Benzbromarone in the Treatment of Gout
- (2009) Ming-Han H Lee et al. DRUG SAFETY
- Uromodulin mutations causing familial juvenile hyperuricaemic nephropathy lead to protein maturation defects and retention in the endoplasmic reticulum
- (2009) Siân E. Williams et al. HUMAN MOLECULAR GENETICS
- Adherence to treatment guidelines in two primary care populations with gout
- (2009) Geoffrey C. Wall et al. RHEUMATOLOGY INTERNATIONAL
- Meta-Analysis of 28,141 Individuals Identifies Common Variants within Five New Loci That Influence Uric Acid Concentrations
- (2009) Melanie Kolz et al. PLoS Genetics
- A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300-600 mg/day versus benzbromarone 100-200 mg/day in patients with gout
- (2008) M K Reinders et al. ANNALS OF THE RHEUMATIC DISEASES
- Long-term Cardiovascular Mortality Among Middle-aged Men With Gout
- (2008) Eswar Krishnan ARCHIVES OF INTERNAL MEDICINE
- Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: A 28-week, phase III, randomized, double-blind, parallel-group trial
- (2008) H. RALPH Schumacher et al. ARTHRITIS AND RHEUMATISM
- Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial
- (2008) Hein JEM Janssens et al. LANCET
- Going from evidence to recommendations
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation